MedTrace Logo

Evaluation of Electronic Florbetapir (18F) Interpretation Training in Japanese Physicians

NCT02029547 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2014-10-23

No results posted yet for this study

Summary

This study is designed to validate the Japanese electronic florbetapir (18F) interpretation training program intended for post-approval implementation in Japan.

Conditions

Interventions

DRUG

Florbetapir (18F)

No Florbetapir (18F) will be administered in this study.

Sponsors & Collaborators

  • Avid Radiopharmaceuticals

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
DIAGNOSTIC
Masking
SINGLE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-10-31
Primary Completion
2015-05-31
Completion
2015-05-31

Countries

  • Japan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02029547 on ClinicalTrials.gov